Zobrazeno 1 - 10
of 180
pro vyhledávání: '"Tervonen TA"'
Autor:
Belitškin D; Research Programs Unit/Translational Cancer Medicine Research Program and Medicum, Faculty of Medicine, University of Helsinki, Finland., Munne P; Research Programs Unit/Translational Cancer Medicine Research Program and Medicum, Faculty of Medicine, University of Helsinki, Finland., Pant SM; Research Programs Unit/Translational Cancer Medicine Research Program and Medicum, Faculty of Medicine, University of Helsinki, Finland., Anttila JM; Research Programs Unit/Translational Cancer Medicine Research Program and Medicum, Faculty of Medicine, University of Helsinki, Finland., Suleymanova I; Research Programs Unit/Translational Cancer Medicine Research Program and Medicum, Faculty of Medicine, University of Helsinki, Finland., Belitškina K; Pathology Department, North Estonia Medical Centre, Tallinn, Estonia., Kirchhofer D; Department of Early Discovery Biochemistry, Genentech, Inc., South San Francisco, CA, USA., Janetka J; Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, MO, USA., Käsper T; Sixfold OÜ, Tartu, Estonia., Jalil S; Stem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Finland., Pouwels J; Research Programs Unit/Translational Cancer Medicine Research Program and Medicum, Faculty of Medicine, University of Helsinki, Finland., Tervonen TA; Research Programs Unit/Translational Cancer Medicine Research Program and Medicum, Faculty of Medicine, University of Helsinki, Finland., Klefström J; Research Programs Unit/Translational Cancer Medicine Research Program and Medicum, Faculty of Medicine, University of Helsinki, Finland.; Foundation for the Finnish Cancer Institute, Helsinki & FICAN South, Helsinki University Hospital, Finland.
Publikováno v:
Molecular oncology [Mol Oncol] 2024 Mar; Vol. 18 (3), pp. 547-561. Date of Electronic Publication: 2023 Nov 13.
Autor:
Tanjore Ramanathan J; Translational Cancer Medicine Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Zárybnický T; Stem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Filppu P; Translational Cancer Medicine Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Monzo HJ; Translational Cancer Medicine Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Monni O; Applied Tumor Genomics Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Tervonen TA; Translational Cancer Medicine Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Finnish genome editing center (FinGEEC), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland., Klefström J; Translational Cancer Medicine Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Finnish Cancer Institute & FICAN South, Helsinki University Hospital (HUS), Helsinki, Finland., Kerosuo L; Neural Crest Development and Disease Unit, Department of Health and Human Services, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, 20892, USA. laura.kerosuo@nih.gov., Kuure S; Stem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland. satu.kuure@helsinki.fi.; GM-unit, Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland. satu.kuure@helsinki.fi., Laakkonen P; Translational Cancer Medicine Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland. pirjo.laakkonen@helsinki.fi.; iCAN Flagship Program, University of Helsinki, Helsinki, Finland. pirjo.laakkonen@helsinki.fi.; Laboratory Animal Centre, Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland. pirjo.laakkonen@helsinki.fi.
Publikováno v:
Scientific reports [Sci Rep] 2023 Oct 11; Vol. 13 (1), pp. 17162. Date of Electronic Publication: 2023 Oct 11.
Autor:
Tervonen TA; Research Programs Unit/Translational Cancer Medicine and Medicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Pant SM; Research Programs Unit/Translational Cancer Medicine and Medicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Belitškin D; Research Programs Unit/Translational Cancer Medicine and Medicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Englund JI; Research Programs Unit/Translational Cancer Medicine and Medicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Närhi K; Research Programs Unit/Translational Cancer Medicine and Medicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland., Haglund C; Research Programs Unit/Translational Cancer Medicine Research Program and Department of Surgery, Clinicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Kovanen PE; Research Programs Unit/Translational Cancer Medicine and Medicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Department of Pathology, HUSLAB and Haartman Institute, Helsinki University Central Hospital and University of Helsinki, Helsinki, Finland., Verschuren EW; Research Programs Unit/Translational Cancer Medicine and Medicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland., Klefström J; Research Programs Unit/Translational Cancer Medicine and Medicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland. juha.klefstrom@helsinki.fi.; Finnish Cancer Institute, FICAN South, Helsinki University Hospital and Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Publikováno v:
Cancer research [Cancer Res] 2021 Mar 15; Vol. 81 (6), pp. 1513-1527. Date of Electronic Publication: 2021 Jan 18.
Autor:
Belitškin D; Research Programs Unit/Translational Cancer Medicine Research Program and Medicum, Faculty of Medicine, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland., Pant SM; Research Programs Unit/Translational Cancer Medicine Research Program and Medicum, Faculty of Medicine, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland., Munne P; Research Programs Unit/Translational Cancer Medicine Research Program and Medicum, Faculty of Medicine, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland., Suleymanova I; Research Programs Unit/Translational Cancer Medicine Research Program and Medicum, Faculty of Medicine, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland., Belitškina K; Pathology Department, North Estonia Medical Centre, Tallinn, Estonia., Hongisto HA; Research Programs Unit/Translational Cancer Medicine Research Program and Medicum, Faculty of Medicine, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland., Englund J; Research Programs Unit/Translational Cancer Medicine Research Program and Medicum, Faculty of Medicine, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland., Raatikainen T; Research Programs Unit/Translational Cancer Medicine Research Program and Medicum, Faculty of Medicine, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland., Klezovitch O; Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Vasioukhin V; Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Li S; Department of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA., Wu Q; Department of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA., Monni O; Research Programs Unit/Applied Tumor Genomics Research Program, Faculty of Medicine, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland., Kuure S; GM-Unit, Laboratory Animal Centre, Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland., Laakkonen P; Laboratory Animal Center, Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland., Pouwels J; Research Programs Unit/Translational Cancer Medicine Research Program and Medicum, Faculty of Medicine, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland., Tervonen TA; Research Programs Unit/Translational Cancer Medicine Research Program and Medicum, Faculty of Medicine, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland., Klefström J; Research Programs Unit/Translational Cancer Medicine Research Program and Medicum, Faculty of Medicine, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland.; Finnish Cancer Institute & FICAN South, Helsinki University Hospital (HUS), Helsinki, Finland.
Publikováno v:
EMBO reports [EMBO Rep] 2021 Nov 04; Vol. 22 (11), pp. e52532. Date of Electronic Publication: 2021 Sep 13.
Autor:
Pant SM; Cancer Cell Circuitry Laboratory, Research Programs Unit/Translational Cancer Biology & Medicum, University of Helsinki , P.O. Box 63, Haartmaninkatu 8 , 00014 Helsinki , Finland., Mukonoweshuro A; Cyclofluidic Ltd. , Biopark, Broadwater Road , Welwyn Garden City , AL7 3AX , U.K., Desai B; Cyclofluidic Ltd. , Biopark, Broadwater Road , Welwyn Garden City , AL7 3AX , U.K., Ramjee MK; Cyclofluidic Ltd. , Biopark, Broadwater Road , Welwyn Garden City , AL7 3AX , U.K., Selway CN; Cyclofluidic Ltd. , Biopark, Broadwater Road , Welwyn Garden City , AL7 3AX , U.K., Tarver GJ; Cyclofluidic Ltd. , Biopark, Broadwater Road , Welwyn Garden City , AL7 3AX , U.K., Wright AG; Cyclofluidic Ltd. , Biopark, Broadwater Road , Welwyn Garden City , AL7 3AX , U.K., Birchall K; LifeArc , Accelerator Building, Open Innovation Campus , Stevenage , SG1 2FX , U.K., Chapman TM; LifeArc , Accelerator Building, Open Innovation Campus , Stevenage , SG1 2FX , U.K., Tervonen TA; Cancer Cell Circuitry Laboratory, Research Programs Unit/Translational Cancer Biology & Medicum, University of Helsinki , P.O. Box 63, Haartmaninkatu 8 , 00014 Helsinki , Finland., Klefström J; Cancer Cell Circuitry Laboratory, Research Programs Unit/Translational Cancer Biology & Medicum, University of Helsinki , P.O. Box 63, Haartmaninkatu 8 , 00014 Helsinki , Finland.
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2018 May 24; Vol. 61 (10), pp. 4335-4347. Date of Electronic Publication: 2018 May 14.
Autor:
Pant SM; Translational Cancer Biology, Research Programs Unit and Medicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Belitskin D; Translational Cancer Biology, Research Programs Unit and Medicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Ala-Hongisto H; Translational Cancer Biology, Research Programs Unit and Medicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Klefström J; Translational Cancer Biology, Research Programs Unit and Medicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Tervonen TA; Translational Cancer Biology, Research Programs Unit and Medicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland. Topi.tervonen@helsinki.fi.
Publikováno v:
Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2018; Vol. 1731, pp. 169-178.
Autor:
Tervonen TA; Cancer Cell Circuitry Laboratory, Research Programs Unit, Translational Cancer Biology and Institute of Biomedicine, University of Helsinki, Helsinki, Finland., Belitškin D; Cancer Cell Circuitry Laboratory, Research Programs Unit, Translational Cancer Biology and Institute of Biomedicine, University of Helsinki, Helsinki, Finland., Pant SM; Cancer Cell Circuitry Laboratory, Research Programs Unit, Translational Cancer Biology and Institute of Biomedicine, University of Helsinki, Helsinki, Finland., Englund JI; Cancer Cell Circuitry Laboratory, Research Programs Unit, Translational Cancer Biology and Institute of Biomedicine, University of Helsinki, Helsinki, Finland., Marques E; Cancer Cell Circuitry Laboratory, Research Programs Unit, Translational Cancer Biology and Institute of Biomedicine, University of Helsinki, Helsinki, Finland., Ala-Hongisto H; Cancer Cell Circuitry Laboratory, Research Programs Unit, Translational Cancer Biology and Institute of Biomedicine, University of Helsinki, Helsinki, Finland., Nevalaita L; Cancer Cell Circuitry Laboratory, Research Programs Unit, Translational Cancer Biology and Institute of Biomedicine, University of Helsinki, Helsinki, Finland., Sihto H; Department of Oncology, University of Helsinki & Helsinki University Central Hospital, Helsinki, Finland., Heikkilä P; Department of Pathology, HUSLAB and Haartman Institute, Helsinki University Central Hospital and University of Helsinki, Helsinki, Finland., Leidenius M; Breast Surgery Unit, Helsinki University Central Hospital, Helsinki, Finland., Hewitson K; Helsinki Innovation Services Ltd, Tukholmankatu 8A, 00290, University of Helsinki, Helsinki, Finland., Ramachandra M; Aurigene Discovery Technologies Limited, 39-40 KIADB Industrial Area, Electronic City Phase II, Bangalore, India., Moilanen A; Orion Corporation, Orion Pharma, Turku, Finland., Joensuu H; Department of Oncology, University of Helsinki & Helsinki University Central Hospital, Helsinki, Finland., Kovanen PE; Department of Pathology, HUSLAB and Haartman Institute, Helsinki University Central Hospital and University of Helsinki, Helsinki, Finland., Poso A; School of Pharmacy, University of Eastern Finland, Kuopio, Finland and Finnish Institute of Molecular Medicine, Helsinki, Finland., Klefström J; Cancer Cell Circuitry Laboratory, Research Programs Unit, Translational Cancer Biology and Institute of Biomedicine, University of Helsinki, Helsinki, Finland.
Publikováno v:
Oncogene [Oncogene] 2016 Apr 07; Vol. 35 (14), pp. 1832-46. Date of Electronic Publication: 2015 Jul 13.
Autor:
Marques E; Cancer Cell Circuitry Laboratory, Research programs unit, Translational Cancer Biology and Institute of Biomedicine, University of Helsinki, Finland., Englund JI; Cancer Cell Circuitry Laboratory, Research programs unit, Translational Cancer Biology and Institute of Biomedicine, University of Helsinki, Finland., Tervonen TA; Cancer Cell Circuitry Laboratory, Research programs unit, Translational Cancer Biology and Institute of Biomedicine, University of Helsinki, Finland., Virkunen E; Cancer Cell Circuitry Laboratory, Research programs unit, Translational Cancer Biology and Institute of Biomedicine, University of Helsinki, Finland., Laakso M; Systems Biology Laboratory, Genome-Scale Biology Program and Institute of Biomedicine, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland., Myllynen M; Cancer Cell Circuitry Laboratory, Research programs unit, Translational Cancer Biology and Institute of Biomedicine, University of Helsinki, Finland., Mäkelä A; Cancer Cell Circuitry Laboratory, Research programs unit, Translational Cancer Biology and Institute of Biomedicine, University of Helsinki, Finland., Ahvenainen M; Cancer Cell Circuitry Laboratory, Research programs unit, Translational Cancer Biology and Institute of Biomedicine, University of Helsinki, Finland., Lepikhova T; Genome-Scale Biology Program and Institute of Biomedicine, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland., Monni O; Genome-Scale Biology Program and Institute of Biomedicine, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland., Hautaniemi S; Systems Biology Laboratory, Genome-Scale Biology Program and Institute of Biomedicine, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland., Klefström J; Cancer Cell Circuitry Laboratory, Research programs unit, Translational Cancer Biology and Institute of Biomedicine, University of Helsinki, Finland.
Publikováno v:
Oncogene [Oncogene] 2016 Mar 17; Vol. 35 (11), pp. 1386-98. Date of Electronic Publication: 2015 Jun 15.
Autor:
Sun, Shijin1,2 (AUTHOR), Hu, Kaixuan1,2 (AUTHOR), Wang, Lina1 (AUTHOR), Liu, Meng1 (AUTHOR), Zhang, Yikai1,2 (AUTHOR), Dong, Ningzheng1,2 (AUTHOR) ningzhengdong@suda.edu.cn, Wu, Qingyu1 (AUTHOR) wuqy@suda.edu.cn
Publikováno v:
FEBS Journal. Aug2023, Vol. 290 Issue 16, p3966-3982. 17p.
Autor:
Partanen JI; Cancer Cell Circuitry Laboratory, Translational Cancer Biology Research Program and Institute of Biomedicine, University of Helsinki, , Biomedicum Helsinki, Rm B507b, PO Box 63, Haartmaninkatu 8, 00014 Helsinki, Finland., Tervonen TA, Klefström J
Publikováno v:
Philosophical transactions of the Royal Society of London. Series B, Biological sciences [Philos Trans R Soc Lond B Biol Sci] 2013 Sep 23; Vol. 368 (1629), pp. 20130111. Date of Electronic Publication: 2013 Sep 23 (Print Publication: 2013).